 |
|
|
|
|
|
|
|
|
|
|
1 to 23 of 23 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Morgan D. on NEWS: Bapineuzumab Phase 3: Target Engagement, But No Benefit, One concern I have with the bapineuzumab trials is that the doses had to be reduced due to the... 13 Sep 2012.
|
|
|
 |
|
|
Morgan D. on PAPER: Cramer PE. et al., 2012, The data presented in this paper show the most rapid removal of Aβ of any systemically applied... 13 Feb 2012.
|
|
|
|
|
|
Morgan D. on NEWS: Smuggling Antibodies to BACE Across the Blood-Brain Barrier, Here is my quick reaction to these intriguing papers, without the benefit of having had time to... 27 May 2011.
|
|
|
|
|
|
Morgan D. on PAPER: Britschgi M. et al., 2009, This is state-of-the-art technology measuring sizable cohorts of human samples and fairly... 13 Jul 2009.
|
|
|
|
|
|
Morgan D. on NEWS: Piping in Passive Immunization Spares Blood Vessels, This is a very important paper that was performed very professionally and addresses a critically... 28 Feb 2009.
|
|
|
|
|
|
Morgan D. on PAPER: Zaghi J. et al., 2009, This paper describes a mechanism by which macrophages may participate in the development of... 29 Jan 2009.
|
|
|
|
|
|
Morgan D. on PAPER: Deane R. et al., 2008, This paper addresses a fundamental question regarding the increased risk of AD in ApoE4... 5 Dec 2008.
|
|
|
|
|
|
Morgan D. on PAPER: Schroeter S. et al., 2008, The manuscript by Schroeter et al. demonstrates that even in middle-aged mice, anti-Aβ... 15 Jul 2008.
|
|
|
|
|
|
Morgan D. on NEWS: Complement: AD Friend or Foe? New Work Tips Balance to Former, This is a very timely and important paper that supports a more sophisticated view of the role of... 23 Jun 2008.
|
|
|
|
|
|
Morgan D. on NEWS: AD Immunotherapy: Toward Prevention, DNA-based Vaccines?, I have a couple of quick points to make. First, Michael Agadjanyan is a brilliant immunologist.... 15 May 2008.
|
|
|
|
|
|
Morgan D. on PAPER: Head E. et al., 2008, I have a couple of thoughts. First, there is no good evidence, other than correlative, that... 5 Apr 2008.
|
|
|
|
|
|
Morgan D. on PAPER: Bos MJ. et al., 2007, This is a very carefully performed prospective study discriminating two types of transient... 5 Feb 2008.
|
|
|
|
|
|
Morgan D. on PAPER: Zurbriggen R. et al., 2005, This paper reports a reduction in soluble, ELISA-assayable Aβ, in the absence of significant... 6 Oct 2005.
|
|
|
|
|
|
Morgan D. on PAPER: Racke MM. et al., 2005, This article points out an important consideration with respect to passive immunotherapy against... 8 Feb 2005.
|
|
|
|
|
|
Morgan D. on NEWS: San Diego: Treating Forgetfulness—Triple Transgenics Provoke, I think this is among the most important observations shown at the meeting. I had seen Frank... 5 Nov 2004.
|
|
|
|
|
|
Morgan D. on NEWS: Tackling Alzheimer’s from the Outside in, There are two key features to this manuscript. The first is the obvious linkage between the... 5 Aug 2004.
|
|
|
|
|
|
Morgan D. on NEWS: Primate Model Promising for Studying Aβ Vaccine, This paper shows that immunization of aged monkeys against the Aβ peptide produces measurable... 15 Mar 2004.
|
|
|
|
|
|
Morgan D. on NEWS: Alzheimer’s Vaccine: In Some Patients, at Least, It Might Just Work, This paper continues the rollercoaster of emotion regarding the use of amyloid vaccines to treat... 21 May 2003.
|
|
|
|
|
|
Morgan D. on NEWS: Following Footsteps of AD Vaccination: Passive Shots Against Prions Protect Mice, This is a very exciting development for a rapidly fatal disease, for which there is no known... 7 Mar 2003.
|
|
|
|
|
|
Morgan D. on NEWS: Pertussis Toxin Stokes Autoimmune Reaction in Aβ-Vaccinated Mice, I’d like to note two additional things that might have relevance here. First, there is a severe... 12 Feb 2003.
|
|
|
|
|
|
Morgan D. on NEWS: The Alzheimer's Vaccination Story, Continued, The paper by Hock et al from the Zurich group was very informative. Perhaps most interesting was... 16 Oct 2002.
|
|
|
|
|
|
Morgan D. on NEWS: Early-Stage Alternative Vaccine Reported: Better Antibody Response with Liposomes?, I think this is a clever approach to producing a vaccine that would seem more cost-effective... 20 Feb 2002.
|
|
|
|
|
|
Morgan D. on LIVE DISCUSSION: Alzheimer Immunotherapy Trial Grounded: Time to Reassess Safety and Vaccine Design, The release from Elan certainly raises more questions for me than it answers. For example, what... 11 Feb 2002.
|
|
|
|
|
|
|
1 to 23 of 23 results |
|
|
|
|
|
|
|
|
|
|
Home
See our latest Webinar: 
